Please use this identifier to cite or link to this item: http://bura.brunel.ac.uk/handle/2438/11463
Full metadata record
DC FieldValueLanguage
dc.contributor.authorThillai, M-
dc.contributor.authorEberhardt, C-
dc.contributor.authorLewin, AM-
dc.contributor.authorPotiphar, L-
dc.contributor.authorHingley-Wilson, S-
dc.contributor.authorSridhar, S-
dc.contributor.authorMacintyre, J-
dc.contributor.authorKon, OM-
dc.contributor.authorWickremasinghe, M-
dc.contributor.authorWells, A-
dc.contributor.authorWeeks, ME-
dc.contributor.authorMitchell, D-
dc.contributor.authorLalvani, A-
dc.date.accessioned2015-10-09T14:42:58Z-
dc.date.available2012-07-16-
dc.date.available2015-10-09T14:42:58Z-
dc.date.issued2012-
dc.identifier.citationPLoS ONE, 7(7): e38083, (2012)en_US
dc.identifier.issn1932-6203-
dc.identifier.urihttp://journals.plos.org/plosone/article?id=10.1371/journal.pone.0038083-
dc.identifier.urihttp://bura.brunel.ac.uk/handle/2438/11463-
dc.description.abstractBackground: The clinical, radiological and pathological similarities between sarcoidosis and tuberculosis can make disease differentiation challenging. A complicating factor is that some cases of sarcoidosis may be initiated by mycobacteria. We hypothesised that immunological profiling might provide insight into a possible relationship between the diseases or allow us to distinguish between them. Methods: We analysed bronchoalveolar lavage (BAL) fluid in sarcoidosis (n = 18), tuberculosis (n = 12) and healthy volunteers (n = 16). We further investigated serum samples in the same groups; sarcoidosis (n = 40), tuberculosis (n = 15) and healthy volunteers (n = 40). A cross-sectional analysis of multiple cytokine profiles was performed and data used to discriminate between samples. Results: We found that BAL profiles were indistinguishable between both diseases and significantly different from healthy volunteers. In sera, tuberculosis patients had significantly lower levels of the Th2 cytokine interleukin-4 (IL-4) than those with sarcoidosis (p = 0.004). Additional serum differences allowed us to create a linear regression model for disease differentiation (within-sample accuracy 91%, cross-validation accuracy 73%). Conclusions: These data warrant replication in independent cohorts to further develop and validate a serum cytokine signature that may be able to distinguish sarcoidosis from tuberculosis. Systemic Th2 cytokine differences between sarcoidosis and tuberculosis may also underly different disease outcomes to similar respiratory stimuli.en_US
dc.description.sponsorshipThis work is supported by the Wellcome Trust (grant code WT085275MA) and the Medical Research Council (grant code G0801620).en_US
dc.language.isoenen_US
dc.publisherPLOSen_US
dc.subjectSarcoidosisen_US
dc.subjectMultiplex cytokine analysisen_US
dc.subjectTuberculosisen_US
dc.subjectBlooden_US
dc.titleSarcoidosis and tuberculosis cytokine profiles: Indistinguishable in bronchoalveolar lavage but different in blooden_US
dc.typeArticleen_US
dc.identifier.doihttp://dx.doi.org/10.1371/journal.pone.0038083-
dc.relation.isPartOfPLoS ONE-
pubs.issue7-
pubs.volume7-
Appears in Collections:Dept of Mathematics Research Papers

Files in This Item:
File Description SizeFormat 
Fulltext.pdf514.05 kBAdobe PDFView/Open


Items in BURA are protected by copyright, with all rights reserved, unless otherwise indicated.